USA Financial Formulas’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-32
| Closed | -$18K | – | 468 |
|
|
2026
Q1 | $18K | Sell |
32
-2,045
| -98% | -$1.31M | ﹤0.01% | 268 |
|
|
2025
Q4 | $1.41M | Sell |
2,077
-1,650
| -44% | -$1.12M | 0.26% | 28 |
|
|
2025
Q3 | $2.38M | Buy |
+3,727
| New | +$2.26M | 0.42% | 22 |
|
|
2024
Q2 | – | Sell |
-1,501
| Closed | -$810K | – | 340 |
|
|
2024
Q1 | $810K | Buy |
1,501
+1,475
| +5,673% | +$806K | 0.13% | 87 |
|
|
2023
Q4 | $14.4K | Sell |
26
-383
| -94% | -$180K | ﹤0.01% | 244 |
|
|
2023
Q3 | $179K | Buy |
409
+408
| +40,800% | +$203K | 0.27% | 98 |
|
|
2023
Q2 | $502 | Hold |
1
| – | – | ﹤0.01% | 429 |
|
|
2023
Q1 | $500 | Buy |
+1
| New | +$479 | ﹤0.01% | 364 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 354 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 382 |
|
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 304 |
|
|
2021
Q4 | $1K | Sell |
1
-1,688
| -100% | -$1.06M | ﹤0.01% | 322 |
|
|
2021
Q3 | $1.05M | Sell |
1,689
-203
| -11% | -$136K | 0.94% | 51 |
|
|
2021
Q2 | $1.2M | Sell |
1,892
-1,608
| -46% | -$888K | 1% | 23 |
|
|
2021
Q1 | $1.71M | Sell |
3,500
-1,175
| -25% | -$589K | 1.39% | 11 |
|
|
2020
Q4 | $2.34M | Sell |
4,675
-1,664
| -26% | -$745K | 1.85% | 9 |
|
|
2020
Q3 | $2.49M | Buy |
+6,339
| New | +$2.34M | 1.88% | 15 |
|
|
2019
Q1 | – | Sell |
-34,410
| Closed | -$8.59M | – | 223 |
|
|
2018
Q4 | $8.59M | Buy |
+34,410
| New | +$7.05M | 2.14% | 8 |
|
|
2018
Q3 | – | Sell |
-2,171
| Closed | -$416K | – | 329 |
|
|
2018
Q2 | $416K | Sell |
2,171
-10
| -0.5% | -$2.06K | 0.1% | 165 |
|
|
2018
Q1 | $417K | Buy |
+2,181
| New | +$403K | 0.1% | 166 |
|
|
2017
Q3 | – | Sell |
-39,372
| Closed | -$6.36M | – | 289 |
|
|
2017
Q2 | $6.36M | Buy |
+39,372
| New | +$6.39M | 1.53% | 14 |
|
|
2017
Q1 | – | Sell |
-5,779
| Closed | -$678K | – | 283 |
|
|
2016
Q4 | $678K | Sell |
5,779
-5,432
| -48% | -$620K | 0.17% | 98 |
|
|
2016
Q3 | $1.26M | Buy |
+11,211
| New | +$1.18M | 0.32% | 73 |
|
|
2015
Q1 | – | Sell |
-5,334
| Closed | -$395K | – | 208 |
|
|
2014
Q4 | $395K | Buy |
+5,334
| New | +$374K | 0.14% | 157 |
|
Other funds holding IDXX
USA Financial Formulas's IDXX Position: Q2 2026 in Review
USA Financial Formulas sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 32 shares — an estimated $18K sold.
USA Financial Formulas first reported a position in IDXX in Q4 2014 and held it in 24 quarters. The position peaked at $8.59M in Q4 2018. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- USA Financial Formulas reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- USA Financial Formulas sold 32 Idexx Laboratories shares in Q2 2026, an estimated $18K.
- USA Financial Formulas first reported a position in Idexx Laboratories in Q4 2014 and held it in 24 quarters.
- USA Financial Formulas's Idexx Laboratories position peaked at $8.59M in Q4 2018.
- 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.